Animal-Free Recombinant PDGF-BB for Reliable and Reproducible Cell Growth and Vascular Research
PDGF-BB plays a central role in cell proliferation, migration, and vascular development, but traditional production systems can introduce variability and translational limitations. ISOKINE® PDGF-BB offers a fully animal-free, plant-based alternative designed for reproducible and high-quality regenerative research.
PDGF-BB is a key growth factor driving mesenchymal cell proliferation, migration, and vascular development. In research and downstream applications, reproducibility and biological relevance are often limited by animal-derived contaminants or inconsistent production systems.
ISOKINE® PDGF-BB (IK1000) addresses these limitations with a fully animal-free, plant-based expression platform. It enables high-quality research aligned with modern ethical and translational standards.
AIM Biotech Platforms: Microphysiological systems for 3D co-culture, organoids, and tissue modelling
Cellix Flow-Based Assays: VenaFlux systems and biochips for vascular biology and shear stress studies
SynVivo Organ-on-a-Chip Platforms: Advanced human-relevant models for oncology, neuroscience, inflammation and toxicology
You can also explore a wider range of NAMs-driven tools and technologies available on our dedicated page: here .
10% Off ISOkine PDGF-BB Orders!
Enjoy reduced pricing on all ISOkine PDGF-BB products (10μg up to 5mg) through June 30, 2026.
The 10% discount is already applied to the listed prices, no promo code required.
*Offer cannot be combined with other discounts, special offers, or existing price agreements.
Key Challenge
Key Challenge
Researchers working with PDGF-BB commonly face:
- Risk of variability linked to animal-derived production systems
- Regulatory and translational constraints in advanced or clinical workflows
- Need for endotoxin-free and xeno-free reagents in sensitive cell systems
- Limited reproducibility in MSC, fibroblast, and angiogenesis assays
These factors can compromise consistency in regenerative and vascular biology studies.
Solution Overview
Solution Overview
ISOKINE® PDGF-BB (IK1000) is a recombinant human PDGF-BB produced in a plant-based (Orfeus™ barley endosperm) expression system, ensuring a fully animal-free and xeno-free production process.
It delivers biologically active PDGF-BB with high purity and validated functionality for robust and reproducible cell signaling studies.
Key Benefits
Key Benefits
- Fully animal-free and xeno-free production using plant-based expression system
- High biological activity with validated stimulation of PDGF signaling (ED50 < 10 ng/mL)
- Excellent purity (>95%) with endotoxin-free profile (intrinsically endotoxin-free system)
- High reproducibility for MSC expansion, fibroblast proliferation, and angiogenesis assays
- Suitable for advanced regenerative medicine and translational research workflows
Key Features
Key Features
-
- Produced in plant-based Orfeus™ expression system (barley endosperm)
- Recombinant human PDGF-BB (Ser82–Thr190)
- Disulfide-linked homodimer (~13.1 kDa)
- Animal-free, endotoxin-free, high-purity protein
- Typical applications:
- Mesenchymal stem cell (MSC) expansion
- Fibroblast proliferation assays
- Angiogenesis and vascular biology models
- Wound healing and tissue regeneration research
Comparison Table
| Feature | ISOkine® PDGF-BB | Competitor 1 | Competitor 2 | Competitor 3 |
|---|---|---|---|---|
| Expression Host | Barley (Plant / Eukaryotic) | E. coli (Bacterial) | HEK293 (Human Mammalian) | E. coli (Bacterial) |
| Endotoxin Status | Undetectable (Biologically Absent) | Controlled (<1 EU/μg) | Low (<1 EU/μg) | Controlled (<1 EU/μg) |
| Folding / PTMs | Eukaryotic - correct disulfide bonds | Prokaryotic - refolded, no PTMs | Human-like PTMs; viral risk | Prokaryotic - refolded |
| ED₅₀ (Specific Activity) | <10 ng/mL (CoA) | 1–3 ng/mL (expected) | 1–3 ng/mL | <12 ng/mL |
| Animal-Free Status | 100% AOF - zero animal inputs | Animal Component Free (ACF) | AOF (but human cell-derived) | ACF |
| Viral / Prion Risk | None (plant origin) | Minimal | Risk of adventitious agents | Minimal |
| Stability | 3 years @ −20°C validated | 12–24 months typical | 12–24 months typical | 12 months |
| Sustainability | Geothermal - low carbon | Industrial energy intensive | High cell culture costs | Industrial |
| Pre-Clinical Grade Docs | PREMIUM grade (IK1000) available | Research grade only | Research grade only | Research grade |
Purified ISOkine® product carries no pyrogenic or pro-inflammatory contaminants, as assayed with monocyte activation test (MAT Assay) using Human 10-plex Cytokine Assay measuring IL-6, TNF-alpha and IL-1 beta induction.
Get Guidance for Your PDGF-BB Applications
Speak with our team to optimize your regenerative medicine and vascular biology workflows using ISOKINE® PDGF-BB.
-
References
Article content created by Tebubio using courtesy materials provided by ORF Genetics.